Search Results - "Yoshimura, Akihiro"

PubPharm (9)

1

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

in: Nature communications | Vol. 11, No. 1 (2020), p. 4607

by Wang, R. | Yamada, T. | Kita, K. | +24

2

The Quality of Life of Patients with Suspected Lung Cancer before and after Bronchoscopy and the Effect of Mirtazapine on the Depressive Status

in: Internal medicine (Tokyo, Japan) | Vol. 59, No. 13 (2020), p. 1605-1610

by Kaneko, Y. | Mouri, T. | Seto, Y. | +9

3

Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer

in: Lung cancer (Amsterdam, Netherlands) | Vol. 137 (2019), p. 108-112

by Yoshimura, A. | Yamada, T. | Miyagawa-Hayashino, A. | +12

4

Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer

in: The oncologist | Vol. 24, No. 8 (2019), p. 1033-e617

by Chihara, Y. | Yoshimura, A. | Date, K. | +12

5

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer

in: Cancer medicine | Vol. 8, No. 4 (2019), p. 1521-1529

by Yamada, T. | Hirai, S. | Katayama, Y. | +14

6

A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer

in: The oncologist | Vol. 24, No. 4 (2019), p. 459-e131

by Yoshimura, A. | Chihara, Y. | Date, K. | +10

7

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

in: Nature communications | Vol. 10, No. 1 (2019), p. 259

by Taniguchi, H. | Yamada, T. | Wang, R. | +21

8

An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer

in: Medicine | Vol. 97, No. 40 (2018), p. e12660

by Yoshimura, A. | Uchino, J. | Tanimura, K. | +12

9

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

in: BMC cancer | Vol. 18, No. 1 (2018), p. 1241

by Yoshimura, A. | Yamada, T. | Okura, N. | +11

1
[1]